Cargando…
Poly-Lysine Dendritic Nanocarrier to Target Epidermal Growth Factor Receptor Overexpressed Breast Cancer for Methotrexate Delivery
A fourth generation poly-lysine dendritic nanocarrier (P(4)LDN)-based targeted chemotherapy for breast cancer is attempted by incorporating an epidermal growth factor receptor (EGFR)-specific short peptide E2 (ARSHVGYTGAR) and the drug methotrexate (MTX) into a nanocarrier system. The drug is incorp...
Autores principales: | Narayanan, Pratibha, Anitha, Anju Krishnan, Ajayakumar, Neethu, Kumar, Kesavakurup Santhosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836561/ https://www.ncbi.nlm.nih.gov/pubmed/35160746 http://dx.doi.org/10.3390/ma15030800 |
Ejemplares similares
-
Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands
por: Anitha, Anju Krishnan, et al.
Publicado: (2022) -
Novel morphologies of poly(allyamine hydrochloride)–methotrexate nanoassemblies for methotrexate delivery
por: Wang, Wei-Yuan, et al.
Publicado: (2018) -
Enhanced ε-Poly-L-Lysine Production by the Synergistic Effect of ε-Poly-L-Lysine Synthetase Overexpression and Citrate in Streptomyces albulus
por: Wang, Aixia, et al.
Publicado: (2020) -
Remdesivir-loaded bis-MPA hyperbranched dendritic nanocarriers for pulmonary delivery
por: Halevas, Eleftherios, et al.
Publicado: (2022) -
Polyester dendrimers: a versatile nanocarrier for target specific drug delivery
por: Aravind, A, et al.
Publicado: (2012)